Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (122)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1287 result(s) found, displaying 1201 to 1225
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Safety alertsPhenylpropanolamine is no longer available in Australia due to safety concerns, including the risk of haemorrhagic stroke. Consult your doctor if you have concerns.
-
Market actionsThe products may be contaminated with bacteria and may pose a risk to health.
-
Market actionsThese products may be contaminated with bacteria and may pose a risk to health.
-
Market actions
-
Market actions
-
Safety alertsParoxetine use in early pregnancy may increase the risk of congenital malformations, particularly heart defects, so women planning to become pregnant or in early pregnancy should consult their doctor.
-
Safety alertsSafety review of SSRI antidepressants for pregnant women due to possible infant heart defects.
-
Safety alertsSafety review of SSRI antidepressants for pregnant women due to potential heart defects in infants, especially with paroxetine.
-
Safety alertsGuidant Australia is issuing hazard alert letters to cardiologists on a fault with a limited number of their implantable pacemakers
-
Market actions
-
Safety alertsSome Ayurvedic medicines have been found to contain toxic heavy metals. We're working on improving quality standards.
-
Market actions
-
Safety alertsWe are advising that some polio vaccines produced between 1957 and 1963 were contaminated with SV40, a simian virus.
-
Safety alertsSSRI antidepressants under review for use in young people due to safety issues.
-
Market actions